Investing Profile

David Bonita

InvestorVC

General Partner at OrbiMed

orbimed.comNew York, New York
Photo of David Bonita, General Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
OrbiMed General Partner
$1M - $75.0M
$4.0M
10
$18B
CompanyStageDateRound SizeTotal Raised
Repare Therapeutics
Series BSep 2019$83M
$83M
Imara
Series BMar 2019$63M
$63M
Co-investors: Joseph Anderson (Soffinova Partners), Mark Chin (Arix Bioscience)
Sublimity Therapeutics
Venture RoundMay 2018$64M
$64M
Tricida
Series CJul 2016$55M
Series BMar 2015$30M
$85M
Clementia Pharmaceuticals
Venture RoundJun 2015$60M
Series AJan 2015$10M
Series AJan 2014$23M
$93M
Co-investors: Jean-François Pariseau (Amplitude VC), David Mott (Mott Family Capital)
Loxo Oncology
Series BMay 2014$24M
$57M
Co-investors: Dov Goldstein (Aisling Capital), Josh Bilenker (Aisling Capital), James Barrett
SI-BONE
Venture RoundApr 2014$33M
$33M